BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kimura H, Fujiwara S. Overview of EBV-Associated T/NK-Cell Lymphoproliferative Diseases. Front Pediatr 2018;6:417. [PMID: 30662890 DOI: 10.3389/fped.2018.00417] [Cited by in Crossref: 12] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Grześk E, Kołtan S, Dąbrowska A, Urbańczyk A, Małdyk J, Małkowski B, Bogiel T, Dębski R, Czyżewski K, Wysocki M, Styczyński J. Case report: Cellular therapy for hydroa vacciniforme-like lymphoproliferative disorder in pediatric common variable immunodeficiency with chronic active Epstein-Barr virus infection. Front Immunol 2022;13:915986. [DOI: 10.3389/fimmu.2022.915986] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Yang R, Ai Y, Liu C, Lu X. Aggressive Natural Killer Cell Leukemia in an Adolescent Patient: A Case Report and Literature Review. Front Pediatr 2022;10:829927. [DOI: 10.3389/fped.2022.829927] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lv K, Yin T, Yu M, Chen Z, Zhou Y, Li F. Treatment Advances in EBV Related Lymphoproliferative Diseases. Front Oncol 2022;12:838817. [PMID: 35515118 DOI: 10.3389/fonc.2022.838817] [Reference Citation Analysis]
4 Escalante GM, Mutsvunguma LZ, Muniraju M, Rodriguez E, Ogembo JG. Four Decades of Prophylactic EBV Vaccine Research: A Systematic Review and Historical Perspective. Front Immunol 2022;13:867918. [DOI: 10.3389/fimmu.2022.867918] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Shafiee A, Shamsi S, Kohandel Gargari O, Beiky M, Allahkarami MM, Miyanaji AB, Aghajanian S, Mozhgani SH. EBV associated T- and NK-cell lymphoproliferative diseases: A comprehensive overview of clinical manifestations and novel therapeutic insights. Rev Med Virol 2022;:e2328. [PMID: 35122349 DOI: 10.1002/rmv.2328] [Reference Citation Analysis]
6 Zanelli M, Sanguedolce F, Palicelli A, Zizzo M, Martino G, Caprera C, Fragliasso V, Soriano A, Gozzi F, Cimino L, Masia F, Moretti M, Foroni M, De Marco L, Pellegrini D, De Raeve H, Ricci S, Tamagnini I, Tafuni A, Cavazza A, Merli F, Pileri SA, Ascani S. EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3). Cancers (Basel) 2021;13:6021. [PMID: 34885131 DOI: 10.3390/cancers13236021] [Reference Citation Analysis]
7 Wong Y, Meehan MT, Burrows SR, Doolan DL, Miles JJ. Estimating the global burden of Epstein-Barr virus-related cancers. J Cancer Res Clin Oncol 2021. [PMID: 34705104 DOI: 10.1007/s00432-021-03824-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
8 Knerr JM, Kledal TN, Rosenkilde MM. Molecular Properties and Therapeutic Targeting of the EBV-Encoded Receptor BILF1. Cancers (Basel) 2021;13:4079. [PMID: 34439235 DOI: 10.3390/cancers13164079] [Reference Citation Analysis]
9 Pharaon RR, Xing Y, Agulnik M, Villaflor VM. The Role of Immunotherapy to Overcome Resistance in Viral-Associated Head and Neck Cancer. Front Oncol 2021;11:649963. [PMID: 34336649 DOI: 10.3389/fonc.2021.649963] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Yamada M, Sakamoto S, Sakamoto K, Uchida H, Shimizu S, Osumi T, Kato M, Shoji K, Arai K, Miyazaki O, Nakano N, Yoshioka T, Fukuda A, Kasahara M, Imadome KI. Fatal Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with virus-infected T cells after pediatric multivisceral transplantation: A proof-of-concept case report. Pediatr Transplant 2021;25:e13961. [PMID: 33368911 DOI: 10.1111/petr.13961] [Reference Citation Analysis]
11 Lungu M, Telehuz A, Voinescu DC, Sapira V, Trifan A, Elkan EM, Fătu A, Creangă VZ, Polinschi M, Stoleriu G, Niculet E. NK/T-cell non-Hodgkin lymphoma: Case report and review of the literature. Exp Ther Med 2021;21:91. [PMID: 33363602 DOI: 10.3892/etm.2020.9523] [Reference Citation Analysis]
12 Chen Z, Wang M, Guan P, Zhao S, Zhang W, Gao L, Tang Y, Li L, Liu W. Comparison of Systemic EBV-positive T-Cell and NK-Cell Lymphoproliferative Diseases of Childhood Based on Classification Evolution: New Classification, Old Problems. Am J Surg Pathol 2020;44:1061-72. [PMID: 32317607 DOI: 10.1097/PAS.0000000000001495] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Charostad J, Nakhaie M, Dehghani A, Faghihloo E. The interplay between EBV and KSHV viral products and NF-κB pathway in oncogenesis. Infect Agent Cancer 2020;15:62. [PMID: 33072180 DOI: 10.1186/s13027-020-00317-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
14 Padilla O, Tam W, Geyer JT. T-cell neoplasms in the spleen. Semin Diagn Pathol 2021;38:135-43. [PMID: 33199090 DOI: 10.1053/j.semdp.2020.10.001] [Reference Citation Analysis]
15 Zhu F, Liu T, Pan H, Xiao Y, Li Q, Liu X, Chen W, Wu G, Zhang L. Long-term outcomes of upfront concurrent chemoradiotherapy followed by P-GDP regimen in newly diagnosed early stage extranodal nasal-type NK/T cell lymphoma: A prospective single-center phase II study. Medicine (Baltimore) 2020;99:e21705. [PMID: 32872045 DOI: 10.1097/MD.0000000000021705] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Fujiwara S, Nakamura H. Animal Models for Gammaherpesvirus Infections: Recent Development in the Analysis of Virus-Induced Pathogenesis. Pathogens 2020;9:E116. [PMID: 32059472 DOI: 10.3390/pathogens9020116] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
17 Lee MS, Hwang S, Kim YE, Suh JK, Kim H, Lee SM, Jeong JY, Kwon S, Lee YJ. Central nervous system vasculitis from Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorder in children: A case report. Brain and Development 2019;41:820-5. [DOI: 10.1016/j.braindev.2019.05.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
18 Li Z, Zhang X, Xue W, Zhang Y, Li C, Song Y, Mei M, Lu L, Wang Y, Zhou Z, Jin M, Bian Y, Zhang L, Wang X, Li L, Li X, Fu X, Sun Z, Wu J, Nan F, Chang Y, Yan J, Yu H, Feng X, Wang G, Zhang D, Fu X, Zhang Y, Young KH, Li W, Zhang M. Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphoma. Nat Commun 2019;10:4209. [PMID: 31527657 DOI: 10.1038/s41467-019-12032-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
19 Shannon-Lowe C, Rickinson A. The Global Landscape of EBV-Associated Tumors. Front Oncol 2019;9:713. [PMID: 31448229 DOI: 10.3389/fonc.2019.00713] [Cited by in Crossref: 101] [Cited by in F6Publishing: 150] [Article Influence: 33.7] [Reference Citation Analysis]